Laura and Ed Thompson with their children Stephen, left to right, Claire and Jane. In 2015 after Ed Thompson enrolled in an experimental psychotherapy trial that used clinical-grade MDMA, also known as the party drug ecstasy, to treat patients suffering from severe cases of post-traumatic stress disorder. Thompson said the experience saved his life and kept his family together. (Handout/Ed Thompson via the Canadian Press)

Final phase of MDMA-assisted psychotherapy trials to kick off in B.C.

Doctors hope to get psychedelic-assisted psychotherapy legalized in Canada and the U.S. by 2021

Ed Thompson remembers the helplessness he felt each of the thousands of times his twin daughters would turn blue and go lifeless in his arms.

The young girls suffered from acute breath-holding spells, an involuntary condition that causes children to pass out, in their case up to 40 times a day.

“Having your kids die in your arms 7,500 times kind of sucks,” he said.

The girls’ conditions eventually improved, but the experience compounded earlier trauma Thompson had witnessed as a firefighter in South Carolina, sending him into a spiral of post-traumatic stress, substance abuse and thoughts of suicide.

That all changed in 2015 after Thompson enrolled in an experimental psychotherapy trial that used clinical-grade MDMA, also known as the party drug ecstasy, to treat patients suffering from severe cases of post-traumatic stress disorder.

Thompson said the experience saved his life and kept his family together.

Now, researchers across North America, including B.C., are gearing up for the third and final stage of trials ahead of plans to legalize psychedelic-assisted psychotherapy in Canada and the United States by 2021.

Vancouver is one of 16 locations in the United States, Canada and Israel where clinicians hope to demonstrate that a drug historically associated with gurus and raves can revolutionize psychotherapy and trauma treatment.

The B.C. Centre on Substance Use will conduct the Vancouver trials as part of a larger research project overseen by the Multidisciplinary Association for Psychedelic Studies, or MAPS, a non-profit pharmaceutical company based in California. Talks are also underway for a Montreal facility to participate.

“We hope to prove that MDMA-assisted psychotherapy is the most effective treatment for PTSD that exists on the planet,” said Mark Haden, a public health professor at UBC. Haden founded the Canadian wing of MAPS and helped organize stage two of the organization’s research trials in Vancouver.

Traditional PTSD treatment focuses on desensitization, which is painful and can last years, or even a lifetime, Haden said, adding that only about 10 to 15 per cent of people successfully recover and the drop-out rate is high.

MDMA-assisted psychotherapy, however, lasts fewer than four months and preliminary studies show two thirds of participants remained free of PTSD one year after treatment, he said.

The experimental trials have been so successful, the U.S. Food and Drug Administration, which overseas the approval and regulation of pharmaceutical drugs, has labelled it a “breakthrough therapy” for PTSD treatment.

Researchers believe the psychedelic drug’s effectiveness is partly due to its ability to dispel a participant’s fear and to boost what Haden called the therapeutic alliance.

“The alliance between the therapist and the subject is … the greatest predictor of success,” Haden said, describing MDMA as an empathogen. “MDMA really, really, really increases bonding between people.”

The therapy involves three psychedelic-assisted psychotherapy sessions lasting eight hours each, as well as 12 therapy sessions without MDMA, which all take place over a three-and-a-half-month period.

Thompson, who participated in the stage two trials, said the drug allowed him to trust his therapists and open up in a way he could not before.

“It wasn’t a party drug. There was no party,” he said, as he described laying on a futon and wearing eye shades for most of the experience. “It wasn’t trippy. I didn’t see things. I didn’t have some miraculous spiritual experience. I didn’t get the urge to get up and dance.

“For the first time in years … I was able to open up and talk painlessly,” he said. “The fear, the barriers were removed and I was able to talk to these people.”

Rick Doblin, who founded MAPS in 1986, said one reason so little effort has been put into researching the therapeutic benefits of psychedelics is that pharmaceutical companies don’t stand to profit from studying compounds that are already in the public domain and cannot be patented.

Phase three will cost $26 million and involve up to 150 study participants. It aims to demonstrate that results obtained in the trial’s second stage are applicable on a larger scale.

Doblin said the FDA has agreed to approve the therapy if stage three studies show the drug is effective and there are no safety issues.

Health Canada gave the green light for the latest round of trials, and discussions are slated to begin in February over what the department will need to see in order to approve the treatment.

Geordon Omand, The Canadian Press

Just Posted

Vancouver Island homeowners buy more earthquake insurance than the rest of B.C.

Insurance Bureau of Canada says that’s because the perception of risk is greater on the Island

Anxiety amongst voters on amalgamation referendum

Non-binding referendum asks Victoria and Saanich residents to endorse citizens’ assembly

District of Oak Bay issues notice to cease tent city

The notice is effective immediately

Missing 72-year-old man last seen in Langford

Albert Bedard has been missing since Oct. 12

Persons Day celebrates historic achievement of five suffragettes

Landmark case 89 years ago declared women “persons” making them eligible for the Senate

WATCH: Twelve Angry Jurors puts a new spin on an old tale

Canadian College of Performing Arts opens season with reworked version of Reginald Rose teleplay

Find your future at Black Press career fair in Victoria

More than 70 booths expected at Bay Street Armoury on Oct. 25

San Group announces plans to build new sawmill in Port Alberni

San Group has purchased 25 acres of Catalyst Paper land for expansion

POLL: Do you support amalgamation for communities in the Capital Region?

Residents in Victoria and Saanich will be voting on Oct. 20 on… Continue reading

Two B.C. cannabis dispensaries raided on legalization day

Port Alberni dispensaries ticketed for “unlawful sale” of cannabis

Canada not sending anyone to Saudi business summit

Sources insist Ottawa never intended to dispatch a delegation this time around

VPD ordered to co-operate with B.C. police watchdog probe

According to the IIO, a court is ordering Vancouver police to co-operate with an investigation into a fatal shooting

Earthquake early-warning sensors installed off coast of B.C.

The first-of-its kind warning sensors are developed by Ocean Networks Canada

B.C. woman looks to reduce stigma surrounding weed-smoking moms

Shannon Chiarenza, a Vancouver mom of two, started weedmama.ca to act as a guide for newcomers to legal cannabis, specifically mothers

Most Read